SCHEMBL4927360

SCHEMBL4927360

CC(=O)c1cccc(NC(=O)CCC(=O)NO)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.66
TP53 P04637 1/20 0.63
RXFP1 Q9HBX9 1/20 0.63
ALDH1A1 P00352 5/20 0.62
MEN1 O00255 4/20 0.62
MAPT P10636 3/20 0.62
RAB9A P51151 1/20 0.62
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
HDAC3 O15379 3/20 0.61
HDAC1 Q13547 3/20 0.61
HDAC2 Q92769 3/20 0.61
HDAC10 Q969S8 3/20 0.61
HDAC11 Q96DB2 3/20 0.61
HDAC8 Q9BY41 3/20 0.61
HDAC6 Q9UBN7 3/20 0.61
HDAC4 P56524 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13480137 0.87 SMN1; SMN2 (0.67) KMT2ATP53RXFP1ALDH1A1MEN1
SCHEMBL5974722 0.87 PARP1 (0.73) KMT2ATP53RXFP1ALDH1A1MEN1
SCHEMBL27674139 0.86 KMT2A (0.64) KMT2ATP53RXFP1ALDH1A1MEN1
SCHEMBL11989152 0.85 KMT2A (0.71) KMT2ATP53RXFP1ALDH1A1MEN1
SCHEMBL6272750 0.85 HPGD (0.74) KMT2ATP53RXFP1ALDH1A1MEN1
SCHEMBL19976712 0.85 KMT2A (0.63) KMT2ATP53RXFP1ALDH1A1MEN1
SCHEMBL11989153 0.85 KMT2A (0.71) KMT2ATP53RXFP1ALDH1A1MEN1
SCHEMBL1925261 0.84 KMT2A (0.62) KMT2ATP53RXFP1ALDH1A1MEN1
SCHEMBL5820518 0.81 L3MBTL1 (0.73) KMT2AALDH1A1MEN1MAPTRAB9A
SCHEMBL5892567 0.81 KMT2A (0.62) KMT2AALDH1A1MEN1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 KMT2A 3374/4885TP53 4175/4885RXFP1 3485/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 KMT2A 3243/4885TP53 4132/4885RXFP1 3683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.